Researchers from Case Western Reserve University and University of Kansas have received a $1.65 million Department of Defense grant to continue developing a neural prosthesis aimed at helping those who suffer from traumatic brain injury (TBI) or stroke to regain motor function.
The prosthesis, called a brain-machine-brain interface (BMBI), has proven successful in restoring motor function in biologic models of TBI. The BMBI records signals from one part of the brain, processes them in real time, then bridges the injury by stimulating a second part of the brain that had lost connectivity.
What if eliminating physical pain was a matter of flipping a switch to block it? No drug needed. When it’s time to stop the block, just turn it off.
Researchers at Case Western Reserve University hope to eventually treat chronic or acute pain by using energy-based neuromodulation technology. The university’s Technology Transfer Office has signed a sponsored research agreement with Halyard Health Inc., in Alpharetta, Ga., near Atlanta, to collaborate on technology development.
Over the past 18 months, Case Western Reserve has used Microsoft HoloLens devices for anatomy and art history, music and sustainability.
Now it’s time to apply them to pure fun.
The university’s Interactive Commons (IC), home to academic innovation in visualization, is offering undergraduate, graduate and professional students a free holographic “haunted house” from 4 to 6 p.m. this Thursday and Friday—and on Halloween.
The Larry Sears and Sally Zlotnick Sears think[box] is rolling out “How to think[box]”—free instructional classes through which students, faculty, staff and community members can develop supplemental skills and learn to use equipment.
The program features seven different workshops:
A team of biomedical engineers at Case Western Reserve University is among seven of 23 research teams from the 2016 I-Corps@Ohio program selected to present to potential investors at the upcoming Ohio Collegiate Venture Showcase. The team will present its new technology in brain tumor treatment management, NeuroRadVision, Oct. 21 in Columbus. The event will highlight teams that exhibited the most successful outcomes from the I-Corps@Ohio training program and offer the most potential for success in the commercialization process.
Pallavi Tiwari, assistant professor of biomedical engineering and an associate member of the Case Comprehensive Cancer Center, is leading the development of NeuroRadVision imaging software that distinguishes between a recurrent brain tumor and benign effects of radiation, which can appear similar on a routine MRI scan and result in unnecessary biopsy surgeries.